National Neuroscience Institute
16
5
7
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
2 terminated/withdrawn out of 16 trials
60.0%
-26.5% vs industry average
19%
3 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Multi-modal Training Program to Promote Physical Activity After Stroke
Role: collaborator
Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
Role: lead
Genotype Guided Antiplatelet Therapy In Ischemic Stroke
Role: lead
RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation
Role: lead
Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)
Role: collaborator
Tocotrienols in Parkinson's Disease (PD)
Role: lead
uSINE-PAMS Artificial Intelligence Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy
Role: lead
[BrainConnexion] - Neurodevice Phase I Trial
Role: lead
Immersive Virtual Reality for Dual-task Training in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial
Role: collaborator
Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage
Role: lead
EGb 761 in the Syndrome of MCI With Concomitant CVD
Role: lead
Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
Role: lead
RIVastigmine In Vascular cognitivE Impairment
Role: collaborator
Acupuncture for Peripheral Neuropathy
Role: collaborator
Neuroprotection With Minocycline Therapy for Acute Stroke Recovery Trial
Role: collaborator
Brain Computer Interface (BCI) Based Robotic Rehabilitation for Stroke
Role: lead
All 16 trials loaded